Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Al Drago - Pool/Getty Images

FDA commissioner Stephen Hahn didn't provide any evidence to support President Trump's claim that 99% of coronavirus cases are "totally harmless" while speaking with ABC's Martha Raddatz.

What he's saying: "Well, what I'd say is, you know, any case, we don't want to have in this country. This is a very rapidly moving epidemic. A rapidly moving pandemic. And any death, any case, is tragic. And we want to do everything we can to prevent that," Hahn said.

  • While speaking at a Fourth of July celebration on Saturday, Trump stated that the U.S. has tested almost 40 million people and "by doing so, we show cases 99% of which are totally harmless," per Politico.

The state of play: Many states, such as Texas, Florida and Arizona, are seeing huge surges in cases after they moved forward with reopenings.

Go deeper: Coronavirus cases skyrocketing among communities of color

Go deeper

Oct 13, 2020 - Health

Where the U.S. has been hit hardest by the coronavirus

Expand chart
Data: JAMA; Map: Danielle Alberti/Axios

There was a 20% increase over expected deaths in the U.S. between March 1 and Aug. 1., per a study published in JAMA on Monday.

Why it matters: Experts say that excess deaths are the best way to measure the true impact of the pandemic, as the number accounts for people who died of the virus itself without being counted and those who died of causes that could have been prevented in non-pandemic times.

Updated Oct 12, 2020 - Politics & Policy

Fauci says it would be "outrageous" if Trump campaign used him in another ad

Anthony Fauci, the government's top infectious diseases expert, told CNN on Monday that the Trump campaign should stop airing an ad that uses comments he made without his permission and out of context.

Why it matters: Fauci describes himself as apolitical and says he has never endorsed a political candidate in five decades of public service. He later told The Daily Beast there's "not a chance" that he would resign if the Trump campaign continued to feature him, but added, "By doing this against my will, they are in effect harassing me."

Oct 13, 2020 - Health

Scientists confirm first documented COVID-19 reinfection in the U.S.

Photo: Allen J. Schaben/Los Angeles Times via Getty Images

A 25-year-old man in Nevada has been identified as the first person in the U.S. to get COVID-19 twice, according to a study published in the medical journal The Lancet on Monday.

Why it matters: The finding indicates that being infected with the virus "might not guarantee total immunity in all cases," the study's researchers write. It also calls into question the value of any potential source or indicator of immunity — whether that's antibody testing, the use of blood plasma as a treatment, or perhaps even a vaccine, per Axios' Sam Baker.